Future Science Group – Medium

Future Science Group

Future Science Group

Is the MMSE fit-for-purpose in cognitive testing for Alzheimer’s disease?

Alzheimer’s disease is the most common form of dementia, affecting an estimated 850,000 people in the UK alone. It is a progressive…

2 min readOct 21, 2016

--

--

Future Science Group
in
Neurology Central Notes

Alzheimer’s antibody trial: is a new treatment in sight?

Neurology Central presents a study carried out in Switzerland that outlines what could be a landmark clinical trial in the search for…

2 min readSep 12, 2016

--

Alzheimer’s antibody trial: is a new treatment in sight?

--

Future Science Group
in
Neurology Central Notes

Controversial neurosurgery: Interview with Charlie Teo

Neurology Central presents a study carried out in America that outlines a strategy for the advancement of precision medicine in the…

6 min readSep 5, 2016

--

Controversial neurosurgery: Interview with Charlie Teo

--

Future Science Group
in
Neurology Central Notes

Personalized treatment for Parkinson’s disease on the horizon

Neurology Central presents a study carried out in American that outlines a strategy for the advancement of precision medicine in the…

2 min readSep 2, 2016

--

Personalized treatment for Parkinson’s disease on the horizon

--

Future Science Group
in
Neurology Central Notes

Maintaining vascular health may help prevent non-Alzheimer’s dementia

Neurology Central presents a study carried out in the Netherlands which investigated whether a multicomponent intervention targeting…

2 min readAug 22, 2016

--

Maintaining vascular health may help prevent non-Alzheimer’s dementia

--

Future Science Group
in
Neurology Central Notes

A new brush sweeps clean: the case for antiviral treatment of Alzheimer’s disease

Neurology Central presents professor Ruth F Itzhaki and research in to Alzheimer’s disease:

4 min readAug 17, 2016

--

A new brush sweeps clean: the case for antiviral treatment of Alzheimer’s disease

--

Future Science Group
in
Neurology Central Notes

Interdisciplinary research into dementia: a personal view

Neurology Central presents professor Frank Gunn- Moore and research in to dementia:

7 min readAug 8, 2016

--

Interdisciplinary research into dementia: a personal view

--

Future Science Group
in
Neurology Central Notes

Ask the experts: should we screen for Alzheimer’s disease?

Part 2: This week’s ‘Ask the experts’ column at Neurology Central with Maria Carrillo (Alzheimer’s Association), Linda Nazarko (London…

3 min readAug 1, 2016

--

Ask the experts: should we screen for Alzheimer’s disease?

--

Future Science Group
in
Neurology Central Notes

Part 3: Ask the experts: should we screen for Alzheimer’s disease?

This week’s ‘Ask the experts’ column with Maria Carrillo (Alzheimer’s Association), Linda Nazarko (London North West Healthcare NHS Trust…

9 min readJul 25, 2016

--

Part 3: Ask the experts: should we screen for Alzheimer’s disease?

--

Future Science Group
in
Neurology Central Notes

Ask the Neurology Experts: Is Alzheimer’s disease transmissible?

Part 1: In this latest instalment of our ‘Ask the Experts’ column at Neurology Central, we ask the question, ‘Is Alzheimer’s disease…

6 min readJul 20, 2016

--

Ask the Neurology Experts: Is Alzheimer’s disease transmissible?

--

Future Science Group

Future Science Group

Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research.

Following

Help
Status
About
Careers
Blog
Privacy
Terms
Text to speech
Teams